In this conversational piece, Warren R. Heymann, MD, highlights the sadness he feels when patients come to him frustrated with anxiety and depression after numerous treatments for their skin condition fail time after time.
In this commentary, Dr. Heymann focuses on new data regarding the biologic treatment, dupilumab, in its first year treating atopic dermatitis.
Read this commentary at the American Academy of Dermatology website.